Scarica l'app Stockscreener
3.85
34.15%
0.98
Dopo l'orario di chiusura:
3.65
-0.20
-5.19%
Metavia Inc Borsa (MTVA) Ultime notizie
MTVA Soars As MetaVia Cardiometabolic Data Ignites Speculative Surge - timothysykes.com
Why MetaVia Stock Is Surging On Friday? - MSN
MTVA Stock Explodes As ADA Conference Catalyst Ignites Momentum - StocksToTrade
MetaVia MTVA Stock Soars On ADA 2026 Cardio Breakthrough Buzz - timothysykes.com
$MetaVia (MTVA.US)$ ok im out now after hold for few days. - Moomoo
Why MetaVia Stock Is Falling On Thursday? - MSN
Maxim Group Maintains MetaVia(MTVA.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Keep an eye on the top gainers and losers in Wednesday's session. - ChartMill
MetaVia announces preclinical study on vanoglipel published - Investing.com UK
MetaVia announces preclinical study on vanoglipel published By Investing.com - Investing.com Australia
MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH - PR Newswire
What's going on in today's session - ChartMill
Let's take a look at the stocks that are in motion in today's session. - ChartMill
MetaVia (MTVA) jumps 45.9% as traders react to ADA 2026 late-breaking poster news - Quiver Quantitative
MTVA Stock Sees Volatile Spike As Traders Eye Cash-Heavy Balance Sheet - StocksToTrade
MTVA Stock Sees Heavy Volatility As Traders Target Key Levels - timothysykes.com
Wondering what's happening in today's pre-market session? - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA - TechStock²
$MetaVia (MTVA.US)$ benefited from pre-m lets focus then for market hour 🫡 - Moomoo
MTVA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20 - GuruFocus
MetaVia Price Target Maintained With a $20.00/Share by HC Wainwright & Co. - Moomoo
Fein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20 - TipRanks
MetaVia to Present Promising Obesity and Diabetes Drug Data on DA-1726 and Vanoglipel at ADA 2026 Scientific Sessions - Minichart
MetaVia Showcases Key Cardiometabolic Data at ADA 2026 - TipRanks
MetaVia highlights promising obesity and metabolic disease drugs at ADA 2026 conference. - Pluang
MetaVia to Present Three Late-Breaking Posters on DA-1726 and Vanoglipel at ADA 2026 - TradingView
MetaVia (MTVA) highlights DA-1726 and vanoglipel data in ADA 2026 posters - Stock Titan
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions - PR Newswire
Cotton Pushes Losses into the Friday Close - Barchart.com
Alyeska (MTVA) holds 508,585 exercisable shares; 9.99% cap limits exercises - Stock Titan
Why Super Micro (SMCI) Shares Are Plunging Today - Barchart.com
Wheat Extends Losses at Midday - Barchart.com
Bunker Hill Mining Corp. (BNKR) ouvre les marchés - Barchart.com
MTVA Technical Analysis | Trend, Signals & Chart Patterns | METAVIA INC (NASDAQ:MTVA) - ChartMill
1 Software Stock on Our Buy List and 2 We Avoid - Barchart.com
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data - TipRanks
MTVA: Strong clinical pipeline in obesity and MASH targets high-growth markets with near-term catalysts - TradingView
MetaVia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
MetaVia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MetaVia (NASDAQ: MTVA) Q1 2026 loss, cash raise and going concern warning - Stock Titan
MetaVia (NASDAQ: MTVA) details Q1 2026 loss and DA-1726 obesity trial progress - Stock Titan
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Meta Stock vs. Google Stock: One Is Clearly the Better Buy for the Next 10 Years - Barchart.com
Soybeans Technicals: Confirming the Double Top - Barchart.com
Cotton Collapsing Early on Thursday - Barchart.com
Soybeans Falling Back Following Trump/Xi meeting - Barchart.com
PPL Q1 Earnings Call Highlights - Barchart.com
OppFi Q1 Earnings Call Highlights - Barchart.com
The 5 Most Interesting Analyst Questions From Cloudflare’s Q1 Earnings Call - Barchart.com
Cotton Close with Modest Wednesday Gains - Barchart.com
MetaVia Moves DA-1726 Into Higher-Dose Territory as Phase 1 Data Build a Compelling Obesity Case - Barchart.com
Why Ford (F) Stock Is Trading Up Today - Barchart.com
5 Revealing Analyst Questions From Dutch Bros’s Q1 Earnings Call - Barchart.com
TradingKey - TradingKey
LB Pharmaceuticals Inc.: Q1 Earnings Snapshot - Barchart.com
AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival? - Barchart.com
Stocks in play: Neo Performance Materials Inc. - Barchart.com
Under Armour (NYSE:UAA) Posts Q1 CY2026 Sales In Line With Estimates But Stock Drops 12.8% - Barchart.com
Plug Power Q1 Earnings Call Highlights - Barchart.com
Hogs Bounce Back - Barchart.com
Shootin' the Bull about undercutting both producers and processors - Barchart.com
FOX Q3 Earnings Call Highlights - Barchart.com
MetaVia to Present New DA-1726 Obesity Data at EASL - TipRanks
MetaVia (NASDAQ: MTVA) highlights DA-1726 obesity data in EASL 2026 late-breaking poster - Stock Titan
Obesity drug DA-1726 earns late-breaking spot at EASL 2026 liver meeting - Stock Titan
How MetaVia (MTVA) is solving the problems its peers cannot (Risk Aversion) 2026-05-11Expert Breakout Alerts - Newser
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):